|
Hot Stock: ImmunoCellular Therapeutics, Shares Gain 5.3% (IMUC)
Feb 04, 2013 (SmarTrend(R) Spotlight via COMTEX) --
ImmunoCellular Therapeutics (NASDAQ:IMUC) is one of today's best performing low-priced stocks, up 5.3% to $2.20 on 2.2x average daily volume. ImmunoCellular Therapeutics has traded 861,000 shares thus far today, vs. average volume of 397,000 shares per day. The stock has outperformed the Dow (5.3% to the Dow's -0.9%) and outperformed the S&P 500 (5.3% to the S&P's -1.0%) during today's trading.
ImmunoCellular Therapeutics, Ltd. is a development stage company that seeks to develop imaging devices with medical diagnostic applications.
Over the past year, ImmunoCellular Therapeutics has traded in a range of $0.98 to $4.00 and is now at $2.20, 124% above that low. Over the past week, the 200-day moving average (MA) has gone down 0.6% while the 50-day MA has advanced 1.8%.
ImmunoCellular Therapeutics has overhead space with shares priced $2.20, or 76.5% below the average consensus analyst price target of $9.38. ImmunoCellular Therapeutics shares should encounter resistance at the 200-day moving average (MA) of $2.65 and support at the 50-day MA of $2.04.
SmarTrend is tracking the current trend status for ImmunoCellular Therapeutics and will alert subscribers who have IMUC in their portfolio or watchlist when shares have changed trend direction.
Write to Chip Brian at cbrian@mysmartrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup
[ Back To Technology News's Homepage ]
|